In principle, the COVID-19 outbreak could provide a compelling new justification for expediting the processing of certain Freedom of Information Act requests related to the pandemic. But it is more likely to slow down the handling of most requests as agency employees work remotely and other concerns are understandably prioritized.
The impact of COVID-19 was surveyed by the Congressional Research Service in Freedom of Information Act (FOIA) Processing Changes Due to COVID-19: In Brief, March 27, 2020.
Other noteworthy new and updated reports from CRS include:
U.S. Role in the World: Background and Issues for Congress, updated March 27, 2020
The Employment-Based Immigration Backlog, March 26, 2020
Demographic and Social Characteristics of Persons in Poverty: 2018, March 26, 2020
Occupational Safety and Health Administration (OSHA): Emergency Temporary Standards (ETS) and COVID-19, March 26, 2020
Arms Control and Nonproliferation: A Catalog of Treaties and Agreements, updated March 26, 2020
Congressional Use of Advisory Commissions Following Crises, CRS In Focus, March 25, 2020
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.